FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure

The departure of Principal Deputy Commissioner Joshua Sharfstein provides FDA an opportunity to take stock of its relationship with the new Congress and to re-evaluate its own organizational structure.